Document ID: chunk:federal_register_of_legislation:F2024L01529:schedule:1
Version: federal_register_of_legislation:F2024L01529
Segment Type: schedule
Provision Reference: sch 1
Character Range: 2188–3279

Schedule 1—Amendments

National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015)

     1.            Schedule 1, after entry for Clonazepam in the form Tablet 2 mg
         insert:
   Tablet 2 mg (S19A)  20  200  2

     1.            Schedule 1, after entry for Deucravacitinib
         insert:
Dienogest  Tablet 2 mg  20  28  5

     1.            Schedule 1, after entry for Ezetimibe in the form Tablet 10 mg
         insert:
   Tablet 10 mg (S19A)  20  30  5

     1.            Schedule 1, entry for Medroxyprogesterone
         omit:
   Injection containing medroxyprogesterone acetate 150 mg in 1 mL  20  1  1

     1.            Schedule 1, entry for Varenicline
         substitute:
Varenicline  Box containing 11 tablets 0.5 mg and 42 tablets 1 mg  20  1    0
             Tablet 1 mg                                           20  56   2
                                                                   20  112  0

     1.            Schedule 2, after entry for Ezetimibe in the form Tablet 10 mg
         insert:
   Tablet 10 mg (S19A)  50  60  5